Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
14.10
-0.39 (-2.69%)
At close: Jun 27, 2025, 4:00 PM
14.00
-0.10 (-0.71%)
After-hours: Jun 27, 2025, 6:14 PM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $2.05 billion as of June 27, 2025. Its market cap has decreased by -31.67% in one year.
Market Cap
2.05B
Enterprise Value
1.05B
1-Year Change
-31.67%
Ranking
Category
Stock Price
$14.10
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.05B, an increase of 8.54%. That is a compound annual growth rate of 1.09%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 713.81B |
Johnson & Johnson | 365.75B |
AbbVie | 329.95B |
Novo Nordisk | 299.93B |
UnitedHealth Group | 274.52B |
Novartis AG | 235.02B |
Abbott Laboratories | 232.56B |
AstraZeneca | 215.99B |